Active — Not RecruitingNot Applicable

Efficacy-Implementation Study for PC CARES in Rural Alaska

United States1,075 participantsStarted 2024-09-12

Plain-language summary

This participatory, pragmatic efficacy-implementation trial evaluates the impact of Promoting Community Conversations About Research to End Suicide (PC CARES) to evaluate Learning Circle (LC) participant outcomes (AIM#1), community-wide diffusion effects, and efficacy by tracking youth impact (AIM#2), while finding sustainable ways to scale PC CARES to other Alaska Native (AN) communities (AIM#3).

Who can participate

Age range

12 Years

Sex

ALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * Anyone aged 12 and over who lives or works in the designated communities may participate in this study.

Questions worth asking your doctor

Bring these to your next appointment. They're a starting point for a shared conversation — not a sign you qualify or a recommendation to enrol.

1Based on my diagnosis and history, is this trial worth exploring for me — or is there a standard treatment we should try first?
2What does this trial's phase tell us about how much is already known about its safety and benefit?
3What would taking part actually involve for me — visits, tests, time, and travel?
4What are the known and possible risks or side effects I should weigh, and how would they be monitored?
5If this trial isn't the right fit, what other options or trials would you suggest I look into?

Generated to help you prepare — always confirm anything about your own eligibility and care with the study team and your doctor.

Questions for the trial coordinator

The trial coordinator is the person who runs the study day to day. These cover the practical side — logistics, costs, and what taking part would actually mean for your life. The study team confirms whether you meet the criteria; these are questions to ask, not a sign you qualify.

1What does taking part actually involve week to week — how many visits, where, and how long does each one take?
2What costs are covered by the study, and what might I have to pay for myself, including travel, parking, or time off work?
3What happens during screening, and what happens if the study team confirms I don't meet the criteria after those tests?
4Who pays for the scans, blood work, and other tests the trial requires — the study, my insurance, or me?
5How will being in the trial affect my regular care, and will my own doctor stay informed and involved?
6Can I leave the trial at any point if I change my mind, and what would happen to my care if I do?

A starting point for the conversation — always confirm anything about your own eligibility, costs, and care with the study team and your doctor.

What they're measuring

Change in Community of Practice (CoP)

Timeframe: Baseline; monthly after each LC, assessed over 5 months; follow-up at 1 month and 6 month after the last LC

Change in Suicide Prevention Knowledge

Timeframe: Baseline; monthly after each LC, assessed over 5 months; follow-up at 1 month and 6 month after the last LC

Change in Self-Efficacy

Timeframe: Baseline; monthly after each LC, assessed over 5 months; follow-up at 1 month and 6 month after the last LC

Change in Youth Connectedness

Timeframe: Baseline; monthly after each LC, assessed over 5 months; and 1 month follow up

Change in Community Protective Factors

Timeframe: Baseline; monthly after each LC, assessed over 5 months; and 1 month follow up

Change in Self-Reported Supportive Interactions with Adults

Timeframe: Baseline; monthly after each LC, assessed over 5 months; and 1 month follow up

Trial details

NCT IDNCT06658808

SponsorUniversity of Michigan

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2029-12

View on ClinicalTrials.gov More Suicide Prevention trials

Plain-language summary

What they're measuring

Change in Community of Practice (CoP)

Timeframe: Baseline; monthly after each LC, assessed over 5 months; follow-up at 1 month and 6 month after the last LC

Change in Suicide Prevention Knowledge

Timeframe: Baseline; monthly after each LC, assessed over 5 months; follow-up at 1 month and 6 month after the last LC

Change in Self-Efficacy

Timeframe: Baseline; monthly after each LC, assessed over 5 months; follow-up at 1 month and 6 month after the last LC

Change in Youth Connectedness

Timeframe: Baseline; monthly after each LC, assessed over 5 months; and 1 month follow up

Change in Community Protective Factors

Timeframe: Baseline; monthly after each LC, assessed over 5 months; and 1 month follow up

Change in Self-Reported Supportive Interactions with Adults

Timeframe: Baseline; monthly after each LC, assessed over 5 months; and 1 month follow up